AI-driven biology is exploding, with giants like Google, OpenAI and Stanford University building scientific agents that read papers, generate hypotheses & design experiments.

But these tools remain siloed in Web2 - disconnected from capital, coordination & shared knowledge.

BioAgents break these barriers by integrating onchain features for data sharing, experiment funding & discovery monetization.

Experiments can start immediately once vetted, rather than languishing in traditional grant cycles, while BioAgents read and write to a decentralized knowledge graph integrated across the Bio network.

Stay tuned for more details on the first BioAgent launches, powered by $BIO